September 16, 2022Open Access

Synthesis, Biological Evaluation, and Molecular Modeling Studies of 1-Aryl-1H-pyrazole-Fused Curcumin Analogues as Anticancer Agents

Key Points

Key points are not available for this paper at this time.

Abstract

) and access wider space at the colchicine-binding site (CBS) than that of colchicine or nocodazole via molecular docking studies. In conclusion, our study serves as a basis for the design of promising synthetic compounds as anticancer agents in the future.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Doan et al. (Fri,) studied this question.

synapsesocial.com/papers/6a1b2e0f8b4bc479d4c3ff32 https://doi.org/https://doi.org/10.1021/acsomega.2c02933

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Stability of curcumin in buffer solutions and characterization of its degradation products1997 · 1,691 citations
2Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain2004 · 1,630 citations
3Curcumin suppresses constitutive activation of STAT‐3 by up‐regulating protein inhibitor of activated STAT‐3 (PIAS‐3) in ovarian and endometrial cancer cells2010 · 142 citations
4Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study2015 · 27 citations
5Pyrazole-based potent inhibitors of GGT1: Synthesis, biological evaluation, and molecular docking studies2016 · 18 citations

KI fragen

Bookmark

View Full Paper